Home: Trophogen Inc. Improving Human and Animal Health With Protein Engineering.










Improving Human and Animal Health With Protein Engineering.

Trophogen, Inc. Announces Signing of Exclusive Global Veterinary License and Purchase Agreement With Zoetis, Inc. for Recombinant Long- Acting and Superactive Bovine Follicle- Stimulating Hormone (rbFSH) Analog for Superovulation in Cows.

June 2nd, 2015 - FOR IMMEDIATE RLEASE Rockville, MD
Trophogen, Inc. today announced that the company has completed a licensing and purchase agreement granting Zoetis Inc., the leading global animal health company, an exclusive license to develop Trophogen’s recombinant modified bovine Follicle- Stimulating Hormone (rbFSH) analog in the field of animal health reproduction.
Read More
Lead Products


1. "Recombinant, long acting, high potency "bovine FSH" super -agonist analog for superovula -tion and embryo transfer in beef and dairy cows - "Licensed to Zoetis, Inc. (see above).

2. "Recombinant, long acting, high potency "equine CG" super -agonist analog for reduced time to & synchronization of estrus in pigs and other animals."

3. "Recombinant, long acting, high potency "human FSH" super -agonist analog for infertility and elective egg banking."

4. "Recombinant, long acting, high potency "human TSH" super -agonist analog for imaging and treatment of thyroid cancer."

"(Click for full listing of: "
Human " or " Animal " products. ")


__________________________________________________________________

Trophogen Inc. 2015

ShareThis Copy and Paste